The development of polyanhydrides for drug delivery applications.
暂无分享,去创建一个
[1] R. Langer,et al. Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers , 1990 .
[2] A. Conix. Aromatic polyanhydrides, a new class of high melting fiber‐forming polymers , 1958 .
[3] A. Friedman,et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.
[4] R. Langer,et al. INTERACTION OF POLYMER MICROSPHERES WITH MUCIN GELS AS A MEANS OF CHARACTERIZING POLYMER RETENTION ON MUCUS , 1991 .
[5] Robert Langer,et al. Hydrolytically degradable amino acid-containing polymers , 1990 .
[6] Kam W. Leong,et al. Synthesis of polyanhydrides: melt-polycondensation, dehydrochlorination, and dehydrative coupling , 1987 .
[7] N. Yoda,et al. Synthesis of Polyanhydride. I. Mixed Anhydride of Aromatic and Aliphatic Dibasic Acids , 1959 .
[8] Robert Langer,et al. Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation , 1987 .
[9] K. Nakajima,et al. Studies on 2-Aziridinecarboxylic Acid. V. Formation of Dehydroamino Acid Containing Peptides via the Isomerization by NaI of 2-Aziridinecarboxylic Acid Containing Peptides , 1982 .
[10] R. Langer,et al. Biodegradable polymers as drug delivery systems , 1990 .
[11] R. Tamargo,et al. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. , 1989, Journal of biomedical materials research.
[12] R. Langer,et al. Polyanhydride microspheres: 3. Morphology and characterization of systems made by solvent removal , 1990 .
[13] R. Langer,et al. Interstitial Drug Therapy for Brain Tumors: A Case Study , 1990 .
[14] R. Langer,et al. Polyanhydride microsphere formulation by solvent extraction. , 1988, Journal of pharmaceutical sciences.
[15] Robert Langer,et al. Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids , 1989 .
[16] H. Winn,et al. Intracerebral drug delivery in rats with lesion-induced memory deficits. , 1989, Journal of neurosurgery.
[17] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. , 1985, Journal of biomedical materials research.
[18] J. W. Hill. STUDIES ON POLYMERIZATION AND RING FORMATION. VI. ADIPIC ANHYDRIDE , 1930 .
[19] W. H. Carothers,et al. STUDIES OF POLYMERIZATION AND RING FORMATION. XIV. A LINEAR SUPERPOLYANHYDRIDE AND A CYCLIC DIMERIC ANHYDRIDE FROM SEBACIC ACID , 1932 .
[20] R Langer,et al. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. , 1986, Journal of biomedical materials research.
[21] R. Langer,et al. Morphology of polyanhydride microsphere delivery systems. , 1990, Scanning microscopy.
[22] R. Tamargo,et al. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. , 1989, Selective cancer therapeutics.
[23] Robert Langer,et al. Polyanhydrides. I: Preparation of high molecular weight polyanhydrides , 1987 .
[24] R. Langer,et al. Polyanhydrides: Stability and novel composition , 1988 .
[25] J. E. Bucher,et al. THE ANHYDRIDES OF ISOPHTHALIC AND TEREPHTHALIC ACIDS. , 1909 .
[26] R. Langer,et al. Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. , 1990, Journal of biomedical materials research.
[27] R. Langer,et al. Polyanhydrides. IV. Unsaturated and crosslinked polyanhydrides , 1991 .
[28] R. Langer,et al. Solid-state and solution stability of poly(anhydrides) and poly(esters) , 1989 .
[29] Robert Langer,et al. Poly(anhydrides). 2. One-step polymerization using phosgene or diphosgene as coupling agents , 1988 .
[30] Robert Langer,et al. Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal , 1988 .